STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells
- Resource Type
- Article
- Source
- In
International Journal of Biological Macromolecules 31 December 2023 253 Part 8 - Subject
- Language
- ISSN
- 0141-8130